✨ Free AI Report
Integra LifeSciences Holdings Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Integra LifeSciences Holdings Corporation
Company Research

Integra LifeSciences Holdings Corporation: Business Overview, Financials & Competitive Analysis

Integra LifeSciences Holdings Corporation scores 3/10 on the AskCyborg Cyborg Score (Challenged). Turnaround candidate with operational progress offset by elevated debt, legacy write-downs, and modest organic growth outlook. The company recorded a $511M goodwill impairment in 2025 and reported a GAAP net loss for the year; leverage remains elevated (net debt ~ $1.6B, ~4.5x leverage), which raises capital-allocation and downside.

What is Integra LifeSciences Holdings Corporation's industry? Integra LifeSciences Holdings Corporation (integralife.com) operates in Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery). AskCyborg classifies Integra LifeSciences Holdings Corporation under Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery) in its company registry.

Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The compan...

3/ 10Challenged

Cyborg Score thesis

Turnaround candidate with operational progress offset by elevated debt, legacy write-downs, and modest organic growth...

Read the full analyst-debate transcript →
Industry Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Integra LifeSciences Holdings Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Integra LifeSciences Holdings Corporation

AskCyborg analysts argue the bull and bear cases for Integra LifeSciences Holdings Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Integra LifeSciences Holdings Corporation OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Integra LifeSciences Holdings Corporation Overview

Pro stress-test →

Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The company operates in the specialized medical device sector, delivering life-saving technologies to healthcare professionals worldwide.

Strategic Profile

Pro stress-test →

Integra is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The company expects flat to low single-digit growth in its Codman Specialty Surgical segment and low to mid-single-digit growth in its Tissue Tech segment for 2026.

Competitive Landscape

Pro stress-test →

Integra LifeSciences is a global medical technology company specializing in products and innovations for neurosurgery, regenerative medicine and reconstructive procedures. The company competes with larger diversified medical device manufacturers and specialized orthopedic/neurosurgery device makers in fragmented markets.

Industry Context

Integra LifeSciences Holdings Corporation operates in Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery).

Key facts

Founded: 1989 · Headquarters: Princeton, New Jersey, United States · Revenue: $1.64B (TTM) · Market cap: $0.9B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Integra LifeSciences Holdings Corporation.

  • Q4 results exceeded expectations with adjusted EPS of $0.83 topping consensus of $0.79; management highlighted operational progress and a simplified operating model expected to deliver $25–$30M of savings in 2026.
  • Company continues to see strong demand across both business segments, with strong momentum expected on Integra Skin to drive full year growth expectations.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Q4 2025 earnings: adjusted EPS $0.83 beat consensus; 2026 guidance $2.30-$2.40 EPS, flat to mid-single-digit revenue growth expected
  • Feb 2026Announced simplified operating model targeting $25-$30M cost savings in 2026
  • +1 moreTrack every material event for Integra LifeSciences Holdings Corporation as it happens. Explore monitoring →
Get alerted when Integra LifeSciences Holdings Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Spinal Fusion & Orthopedic DevicesMajor competitor in neurosurgery and spine markets→Surgical Instruments & Regenerative MedicineCompetitor in orthopedic reconstruction and tissue regeneration→Neurosurgical DevicesCompetitor in surgical navigation and neurosurgical instruments→

Compare Integra LifeSciences Holdings Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Integra LifeSciences Holdings Corporation operates in Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery). See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery) research →
NEW · MCP server

Ask your AI assistant about Integra LifeSciences Holdings Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Integra LifeSciences Holdings Corporation and its top competitor on Cyborg Score”
“What did Integra LifeSciences Holdings Corporation do this quarter?”
“Is Integra LifeSciences Holdings Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Integra LifeSciences Holdings Corporation do?+
Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The compan...
What is Integra LifeSciences Holdings Corporation's Cyborg Score?+
Integra LifeSciences Holdings Corporation has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Integra LifeSciences Holdings Corporation's main competitors?+
Named competitors include Spinal Fusion & Orthopedic Devices, Surgical Instruments & Regenerative Medicine, Neurosurgical Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Integra LifeSciences Holdings Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Integra LifeSciences Holdings Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Integra LifeSciences Holdings Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.